Your browser doesn't support javascript.
loading
The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia.
Alarfaj, Sumaiah J; Alzahrani, Abdullah; Alotaibi, Anfal; Almutairi, Malak; Hakami, Mashael; Alhomaid, Njood; Alharthi, Noori; Korayem, Ghazwa B; Alghamdi, Abdullah.
Affiliation
  • Alarfaj SJ; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Alzahrani A; Department of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
  • Alotaibi A; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Almutairi M; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Hakami M; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Alhomaid N; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Alharthi N; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Korayem GB; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Alghamdi A; Internal Medicine Department, Security Forces Hospital, Riyadh, Saudi Arabia.
Saudi Pharm J ; 30(10): 1448-1453, 2022 Oct.
Article in En | MEDLINE | ID: mdl-36387341
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies / Risk_factors_studies Language: En Journal: Saudi Pharm J Year: 2022 Document type: Article Affiliation country: Saudi Arabia Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies / Risk_factors_studies Language: En Journal: Saudi Pharm J Year: 2022 Document type: Article Affiliation country: Saudi Arabia Country of publication: